{"address1": "#140, 14315 \u2013 118 Avenue", "city": "Edmonton", "state": "AB", "zip": "T5L 4S6", "country": "Canada", "phone": "250-744-2487", "fax": "250-708-4345", "website": "https://www.auriniapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aurinia Pharmaceuticals Inc., a biopharmaceutical company, focuses on delivering therapies to treat autoimmune diseases with unmet medical needs in the United States. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.", "fullTimeEmployees": 130, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter S. Greenleaf M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1573362, "exercisedValue": 0, "unexercisedValue": 4336000}, {"maxAge": 1, "name": "Mr. Joseph M. Miller CPA", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 883190, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew Maxwell Donley M.B.A.", "age": 55, "title": "Chief Operations Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 901844, "exercisedValue": 0, "unexercisedValue": 772500}, {"maxAge": 1, "name": "Mr. Stephen P. Robertson", "age": 42, "title": "Executive Vice President of General Counsel", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 836382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea Levin Christopher", "title": "Executive Director of Corporate Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregory F. Keenan M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Premchandran  Ramiya Ph.D.", "age": 63, "title": "Senior Vice President of Manufacturing & Supply Chain", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 10, "compensationRisk": 6, "shareHolderRightsRisk": 2, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.isotechnika.com/for_investors/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.04, "open": 8.075, "dayLow": 7.975, "dayHigh": 8.225, "regularMarketPreviousClose": 8.04, "regularMarketOpen": 8.075, "regularMarketDayLow": 7.975, "regularMarketDayHigh": 8.225, "payoutRatio": 0.0, "beta": 1.266, "trailingPE": 201.25002, "forwardPE": 14.907407, "volume": 1616516, "regularMarketVolume": 1616516, "averageVolume": 1444983, "averageVolume10days": 1170490, "averageDailyVolume10Day": 1170490, "bid": 7.0, "ask": 9.18, "bidSize": 1, "askSize": 1, "marketCap": 1105579008, "fiftyTwoWeekLow": 4.71, "fiftyTwoWeekHigh": 10.67, "priceToSalesTrailing12Months": 4.7019305, "fiftyDayAverage": 8.0968, "twoHundredDayAverage": 7.3709, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 826509056, "profitMargins": 0.02446, "floatShares": 133424854, "sharesOutstanding": 137339008, "sharesShort": 11441156, "sharesShortPriorMonth": 9970652, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0833, "heldPercentInsiders": 0.07478, "heldPercentInstitutions": 0.45196998, "shortRatio": 6.18, "shortPercentOfFloat": 0.0838, "impliedSharesOutstanding": 137339008, "bookValue": 2.679, "priceToBook": 3.0048528, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 5752000, "trailingEps": 0.04, "forwardEps": 0.54, "enterpriseToRevenue": 3.515, "enterpriseToEbitda": 25.857, "52WeekChange": 0.554054, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 8.05, "targetHighPrice": 12.0, "targetLowPrice": 8.0, "targetMeanPrice": 9.83333, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 358439008, "totalCashPerShare": 2.61, "ebitda": 31964000, "totalDebt": 79369000, "quickRatio": 4.046, "currentRatio": 4.568, "totalRevenue": 235132992, "debtToEquity": 21.026, "revenuePerShare": 1.644, "returnOnAssets": 0.01424, "returnOnEquity": 0.01523, "grossProfits": 186100000, "freeCashflow": 62937500, "operatingCashflow": 44388000, "revenueGrowth": 0.328, "grossMargins": 0.79147005, "ebitdaMargins": 0.13594, "operatingMargins": 0.12999, "financialCurrency": "USD", "symbol": "AUPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": 0.04, "epsForward": 0.54, "epsCurrentYear": 0.465, "priceEpsCurrentYear": 17.311829, "fiftyDayAverageChange": -0.04679966, "fiftyDayAverageChangePercent": -0.0057800193, "twoHundredDayAverageChange": 0.67910004, "twoHundredDayAverageChangePercent": 0.092132576, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChangePercent": 0.12438096, "regularMarketPrice": 8.05, "shortName": "Aurinia Pharmaceuticals Inc", "longName": "Aurinia Pharmaceuticals Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1409751000000, "preMarketChange": 0.13999939, "preMarketChangePercent": 1.7391229, "preMarketPrice": 8.19, "regularMarketChange": 0.010000229, "regularMarketDayRange": "7.975 - 8.225", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1444983, "fiftyTwoWeekLowChange": 3.3400002, "fiftyTwoWeekLowChangePercent": 0.7091295, "fiftyTwoWeekRange": "4.71 - 10.67", "fiftyTwoWeekHighChange": -2.62, "fiftyTwoWeekHighChangePercent": -0.24554825, "fiftyTwoWeekChangePercent": 55.405403, "earningsTimestamp": 1740654000, "earningsTimestampStart": 1746016200, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743584586, "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_882669", "displayName": "Aurinia Pharmaceuticals", "trailingPegRatio": null}